Latest filing published 02 Oct 2020 for PMV Pharmaceuticals, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
Arnold L. Oronsky discloses dealings in 9 companies, chiefly TESARO, Inc., Myogen Inc and PMV Pharmaceuticals, Inc. The record holds 63 filings, for trades running from 13 November 2006 to 29 September 2020.
The open-market side counts 13 purchases for €19.8M alongside 2 sales for €5.6M. The net balance comes to €14.3M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 13 share grants and 4 option exercises. So far in 2020, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €848k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 2 October 2020, the filings show a transaction in PMV Pharmaceuticals, Inc. The most recent open-market purchase was published on 2 October 2020, 2,213 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations